NCT05343767View on ClinicalTrials.gov

Investigate the Efficacy and Safety of Low-Glu in Patients Newly Diagnosed With Type II Diabetes Mellitus

NACompletedINTERVENTIONAL

Enrollment

198

Participants

Timeline

Start Date

September 12, 2018

Primary Completion Date

May 30, 2021

Study Completion Date

May 30, 2021

Conditions

Type2 Diabetes Mellitus

Interventions

DIETARY_SUPPLEMENT

Natural Wellness Low-Glu low dose

The contents of 4 capsules of NW Low-Glu were equally distributed and inserted into 6 capsules size 0, and administered in 3 daily doses

DIETARY_SUPPLEMENT

Natural Wellness Low-Glu high dose

The contents of 5 capsules of NW Low-Glu were equally distributed and inserted into 6 capsules size 0, and administered in 3 daily doses

OTHER

Metformin

A total dose of 2000 mg was administered per day.

Trial Locations (1)

11765

Natural Welness Egypt, Cairo

All Listed Sponsors

lead

Natural Wellness Egypt

INDUSTRY

NCT05343767 - Investigate the Efficacy and Safety of Low-Glu in Patients Newly Diagnosed With Type II Diabetes Mellitus | Biotech Hunter | Biotech Hunter